Cite
HARVARD Citation
Hewitt, D. et al. (2022). A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer. Annals of surgery. 275 (1), p. . [Online].